IRWD
NASDAQStockIronwood Pharmaceuticals, Inc.
$3.39-0.29 (-8.02%)
52-Week Range
$0.57
$5.39
Key Stats
Market Cap
552.8M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.19
Volume
1.1M
Avg Volume
3.7M
Performance
1M
-23.87%
3M
-5.85%
6M
+164.06%
YTD
-20.84%
1Y
+123.84%
3Y
-68.47%
5Y
-69.62%
Price Chart
ETF Exposure
IRWD is held by 66 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About IRWD ETF Exposure
Ironwood Pharmaceuticals, Inc. (IRWD) is held by 66 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 552.8M, IRWD is a widely held institutional stock. The stock currently trades at $3.39. Investors can gain exposure to IRWD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IRWD, sorted by portfolio weight.